Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Cancer therapy: not only cancer cells but cancer stem cells

  • At: 2014 FIP Congress in PSWC, Melbourne (Australia)
  • Type: Poster
  • By: KIM, Jin-Seok (Sookmyung Women's university, College of Pharmacy, Seoul, South-Korea)
  • Co-author(s): Shin, Dae Hwan (Sookmyung Women's university, Seoul, South-Korea)
    Xuan, Shuahua (Sookmyung Women's university, Seoul, South-Korea)
    Lee, Seung Youn (Sookmyung Women's university, Seoul, South-Korea)
    Lee, Ji Yeon (Sookmyung Women's university, Seoul, South-Korea)
  • Abstract:

    Purpose. CD133 has recently been considered as a general CSC marker for many tumor types, especially in GBM, and GBM-CD133+ cells display glioma stem cells (GSCs) properties and appear to be highly tumorigenic. To design drug delivery systems to target the CD133+ cells, PEGylated liposomes encapsulating gemcitabine or GSISs are conjugated with..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses